Pasar al contenido principal

DOMINIOS DE UNION DE CALMODULINA DEL EJE ERBB2/C-SRC/GRB7 COMO DIANAS TERAPEUTICAS EN METASTASIS DE CANCER DE MAMA

SAF2014-52048-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

The activating role of phospho-(Tyr)-calmodulin on the epidermal growth factor receptor

  • Stateva, Silviya R.
  • Salas, Valentina
  • Benguría, Alberto
  • Cossío, Itziar
  • Anguita, Estefanía
  • Martín-Nieto, José
  • Benaim, Gustavo
  • Villalobo Polo, Antonio
  • Martín-Nieto, José|||/items/60fd3a13-a3fb-4bab-8fb1-8c983ba26a4e
The activity of calmodulin (CaM) is modulated not only by oscillations in the cytosolic concentration of free Ca2+, but also by its phosphorylation status. In the present study, the role of tyrosine-phosphorylated CaM [P-(Tyr)-CaM] on the regulation of the epidermal growth factor receptor (EGFR) has been examined using in vitro assay systems. We show that phosphorylation of CaM by rat liver solubilized EGFR leads to a dramatic increase in the subsequent phosphorylation of poly-L-(Glu:Tyr) (PGT) by the receptor in the presence of ligand, both in the absence and in the presence of Ca2+. This occurred in contrast with assays where P-(Tyr)-CaM accumulation was prevented by the presence of Ca2+, absence of a basic cofactor required for CaM phosphorylation and/or absence of CaM itself. Moreover, an antibody against CaM, which inhibits its phosphorylation, prevented the extra ligand-dependent EGFR activation. Addition of purified P-(Tyr)-CaM, phosphorylated by recombinant c-Src (cellular sarcoma kinase) and free of non-phosphorylated CaM, obtained by affinity-chromatography using an immobilized anti-phospho-(Tyr)-antibody, also increased the ligand-dependent tyrosine kinase activity of the isolated EGFR toward PGT. Also a CaM(Y99D/Y138D) mutant mimicked the effect of P-(Tyr)-CaM on ligand-dependent EGFR activation. Finally, we demonstrate that P-(Tyr)-CaM binds to the same site (645R-R-R-H-I-V-R-K-R-T-L-R-R-L-L-Q660) as non-phosphorylated CaM, located at the cytosolic juxtamembrane region of the EGFR. These results show that P-(Tyr)-CaM is an activator of the EGFR and suggest that it could contribute to the CaM-mediated ligand-dependent activation of the receptor that we previously reported in living cells.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Regulation of the EGFR by calmodulin: mechanism and therapeutic implications

  • Villalobo, Antonio
Trabajo presentado al XIV International Meeting of the European Calcium Society: Calcium Signaling in Renaissance, celebrado en Valladolid (España) del 25 al 29 de septiembre de 2016., The epidermal growth factor receptor (EGFR/HER1/ErbB1) is a tyrosine kinase that belongs to the ErbB family, and is implicated in multiple cellular functions including: cell proliferation, cell survival, differentiation and cell migration, and is mutated or overexpressed in multiple solid tumors. We have demonstrated that the EGFR, and its cousin ErbB2/HER2, binds calmodulin (CaM) at the cytosolic juxtamembrane region in a Ca2+-dependent manner, participating in the ligand-dependent activation of the receptor as an intracellular co-activator. Deletion or mutation of the CaM-binding domain (CaMBD) of the EGFR inactivated or strongly decreased the tyrosine kinase activity of the receptor. Inhibition of CaM with specific cell-permeable chemical antagonists or downregulation of CaM in conditionalknockout cells stably expressing the human EGFR also inhibited the ligand-dependent activation of the receptor. Furthermore, CaM can be phosphorylated by the EGFR at both Tyr99 and Tyr138 in the absence of Ca2+. We will present results showing that phospho-Tyr-CaM also acts as an activator of the EGFR in the presence but not in the absence of receptor ligand, increasing therefore the tyrosine kinase activity of the receptor toward exogenous substrates. A cell-permeable peptide corresponding to a modified sequence of the CaM-BD of the EGFR also inhibited the ligand-dependent activation of the receptor and the proliferative capacity of cells overexpressing this receptor. A model describing how Ca2+/CaM and phospho-Tyr-CaM exert its activator action, and how targeting the CaM-BD of the EGFR, and ErbB2, could be a valid therapeutic strategy against tumors with overexpressed or dysregulated hyperactive receptors will be discussed., This work was funded by the Secretaría de Estado de Investigación, Desarrollo e Innovación (SAF2014-52048-R), and the CSIC program i-COOP+2014 (COOPA20053)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Efecto de un péptido sintético con la secuencia del dominio de unión de la calmodulina de Grb7 en la proliferación y migración de células tumorales

  • Alcalde Gómez, Juan
Proyecto de Investigación Final de Licenciatura: Licenciatura en Análisis Clínicos y Salud Pública., [ES] La metástasis causa el 90% de las muertes asociadas al cáncer. Este proceso depende de alteraciones en la célula tumoral como son una motilidad incrementada y desarrollo de capacidad invasiva. Las células tumorales A431 sobreexpresan el receptor del factor de crecimiento epidérmico (EGFR), receptor que se localiza en la membrana plasmática y participa en el envío de señales internas que activan mecanismos que estimulan la división celular y su motilidad. Dicha señalización es regulada por la calmodulina (CaM), proteína que a su vez regula la funcionalidad de la proteína adaptadora Grb7 de manera dependiente de Ca2+ y que también se asocia al EGFR y participa en procesos de proliferación y migración celular uniéndose a ella en su dominio 243RKLWKRFFCFLRRS256. Este estudio pretende determinar si células tumorales tratadas con péptidos sintéticos constituidos por la secuencia del sitio de unión de la CaM de Grb7 ven afectada su capacidad proliferativa y migratoria bajo la premisa de que estos péptidos pudieran secuestrar e inactivar la CaM e impedir por tanto que regule dichos procesos. Para ello, se realizaron ensayos de proliferación celular y cierre de herida artificial con células A431 y se compararon los resultados de estos experimentos en presencia de los péptidos, inhibidores de CaM de alta y baja afinidad y controles sin ningún tratamiento. Se observó un efecto inhibidor sobre la proliferación y migración celular por parte de los péptidos sintéticos aunque no de la forma que se esperaba, siendo este efecto además diferente que el provocado por los inhibidores conocidos de CaM. No obstante, los resultados si ofrecieron suficiente evidencia para considerar los péptidos aptos para continuar investigando en la misma dirección ya que todavía es necesaria la realización de distintos experimentos para acercarse a los objetivos planteados., [EN] Metastases causes the 90% of cancer-associated deaths. This process depends on tumor cells alterations including increased motility and invasiveness. A431 tumor cells over-express the epidermal growth-factor receptor (EGFR), that is located in the plasma membrane and plays a role in intracellular signaling which actives cell proliferation and migration. That signaling is regulated by calmodulin (CaM), a protein that also regulates the functionality of the adaptor protein Grb7 (growth factor receptor-bound protein 7) in a Ca2+ dependent manner to its 243RKLWKRFFCFLRRS256 domain. Grb7 also participates in cell proliferation and migration processes. This study expects to determinate whether tumor cells treated with synthetic peptides based in the CaM-binding domain of Grb7 sequence shows any effect in their proliferative and migratory capacity, under the premise of these peptides could sequestrate and inactivate CaM and therefore prevents the regulation of these processes. Different cell proliferation and wound healing assays with A431 cells were performed, and the results in the presence of the synthetic peptides, high and low affinity CaM inhibitors and non-treated controls were compared. Inhibitory effects of the synthetic peptides on cell proliferation and migration was observed, despite the fact that they were not as expected, when compared with the effects caused by the CaM inhibitors. Nevertheless, the results offered enough evidence to consider the peptides adequate to continue working in the same direction considering that it is still necessary to perform additional experiments to get closer to the objetives marked in this project., El trabajo en el laboratorio del autor está financiado mediante la concesión de fondos al Dr. Antonio Villalobo Polo por la Secretaría de Estado de Investigación, Desarrollo e Innovación ref. SAF2014-52048-R, y por la Consejería de Educación, Juventud y Deportes – Comunidad de Madrid ref. B2017/BMD-36, Peer reviewed